Company Filing History:
1 out of 1,830 
1 out of 330 
Years Active: 2005-2009
Title: The Innovative Contributions of Stefan Schäfer
Introduction
Stefan Schäfer is a notable inventor based in Sulzbach, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of metabolic diseases. His work has led to the development of innovative solutions that address critical health issues.
Latest Patents
Stefan Schäfer holds a patent for the "Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases." This invention describes and claims the use of vasopeptidase inhibitors for treating nephropathy in both diabetic and non-diabetic patients. The patent covers various conditions, including diabetic nephropathy, glomerulonephritis, and complications associated with advanced glycation end-products.
Career Highlights
Stefan Schäfer is associated with Aventis Pharma Deutschland GmbH, where he has contributed to groundbreaking research and development in pharmaceuticals. His expertise in metabolic diseases has positioned him as a key figure in the industry.
Collaborations
Throughout his career, Stefan has collaborated with esteemed colleagues such as Wolfgang Linz and Markus Bleich. These partnerships have fostered innovation and have been instrumental in advancing research in their respective fields.
Conclusion
Stefan Schäfer's contributions to medical science through his patent and collaborations highlight his commitment to improving health outcomes. His work continues to influence the treatment of metabolic diseases and nephropathy, showcasing the importance of innovation in healthcare.